HPMC & sodium hyaluronate cause IOP increases

Article

Sodium hyaluronate 1% and hydroxypropylmethylcellulose 2% (HPMC) can cause significant intraocular pressure (IOP) increases during the first eight hours following cataract surgery.

Sodium hyaluronate 1% and hydroxypropylmethylcellulose 2% (HPMC) can cause significant intraocular pressure (IOP) increases during the first eight hours following cataract surgery, according to a study published in the June issue of Ophthalmology.

Georg Rainer and colleagues from the Medical University of Vienna, Austria enrolled 80 eyes of 40 patients with bilateral age-related cataract. The subjects were randomized to receive either sodium hyaluronate 1% or HPMC 2% during cataract surgery of the first eye. The second eye received an alternative viscosurgical device. IOP was measured preoperatively and 30 minutes, one, two, three, four, six, eight, 20 and 24 hours and one week postoperatively.

The researchers found that the highest mean IOP increase occurred at eight hours postoperatively (5.3±6.4 mmHg) in the sodium hyaluronate 1% group and at two hours postoperatively in the HPMC 2% group (7.8±6.1 mmHg). The mean IOP increase was higher in the HPMC 2%group (r=0.005). IOP spikes (≥30 mmHg) were seen in five eyes (13%) of the sodium hyaluronate 1% group and 13 eyes (33%) of the HPMC 2% group.

It was concluded from the study results that both sodium hyaluronate 1%% and HPMC 2% can cause significant IOP increases during the first eight hours following surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.